Researchers at King Abdullah University of Science and Technology (KAUST), in collaboration with the University of Oxford, have developed a blood-based electronic sensor capable of detecting molecular signatures associated with Parkinson’s disease. Published in Science Advances, the technology uses an organic electrochemical transistor (OECT) to simultaneously detect three forms of alpha-synuclein protein at extremely low concentrations within 40 minutes. The platform achieved 90.9% accuracy in distinguishing disease-associated profiles from healthy controls in a blinded evaluation involving 59 participants. Why it matters: This technology could enable earlier and more accurate diagnosis of Parkinson's disease, aligning with Saudi Arabia's Vision 2030 goals for improved healthcare and prevention of age-related diseases.
KAUST and King Faisal Specialist Hospital and Research Centre (KFSH&RC) are collaborating to develop bioelectronic sensors for rapid pathogen detection. These sensors aim to provide cheap and accurate results, potentially replacing conventional lab tests. A COVID-19 saliva test developed by KAUST researchers showed comparable sensitivity to PCR tests with a 15-minute turnaround. Why it matters: This partnership accelerates the development of novel diagnostic tools, which could improve healthcare accessibility in remote areas and low-income countries within the region.
KAUST's Sciencetown podcast episode 23 features researcher Dana Al-Sulaiman discussing portable biosensing technologies for cancer detection. These devices aim to enable liquid biopsies for early screening and personalized treatment. The biosensors gather clinical information from biological samples to inform clinical decisions. Why it matters: This research can advance non-invasive diagnostics and personalized medicine in the region.
KAUST master's student José Ilton de Oliveira Filho won first place at the IEEE International Sensors and Measurement Systems Student Contest for his smart bracelet and gesture-capturer designed for people with Parkinson's disease. The bracelet assists users in basic activities and creates a database for tracking the disease's involuntary tremors. The bracelet can also control smart TVs and enable smoother application navigation. Why it matters: This project demonstrates KAUST's commitment to developing innovative technologies that address real-world healthcare challenges and improve the quality of life for individuals with special needs.
An AI tool has reportedly been developed that can detect pancreatic cancer up to three years before a clinical diagnosis. This finding, based on a new study, was highlighted in a report by The National. The tool aims to significantly improve early detection capabilities for a challenging disease. Why it matters: Early and accurate detection of pancreatic cancer could lead to earlier interventions and substantially improve patient outcomes and survival rates.